Moleculin Biotech is trading at $0.40 (-5.69%) in pre-market following a sharp post-offering selloff triggered by a discounted $9.3 million public offering.
- Traders are reacting to dilution pressure and thin trading volumes following Monday's weakness.
- The stock has experienced significant volatility in recent sessions, including a steep decline in late July.